FINISHED DOSAGE FORMULATIONS
Drug : LANTUS SOLOSTAR
Dosage Form : INJECTABLE; INJECTION
Application Number : 21081
Country : US
Patented : No
Drug : LANTUS
Dosage Form : INJECTABLE; INJECTION
Application Number : 21081
Country : US
Patented : No
Drug : CALCIJEX
Dosage Form : INJECTABLE; INJECTION
Application Number : 18874
Country : US
Patented : No
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN
Drug : AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
Dosage Form : TABLET; ORAL
Application Number : 201087
Country : US
Patented : No
Drug : TRAMADOL HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 76003
Country : US
Patented : No
Drug : MYALEPT
Dosage Form : INJECTABLE; INJECTION
Application Number : 125390
Country : US
Patented : No
Drug : AVONEX
Dosage Form : VIAL
Application Number : 103628
Country : US
Patented : No
Drug : BEXAROTENE
Dosage Form : CAPSULE; ORAL
Application Number : 203174
Country : US
Patented : No
Drug : KINEVAC
Dosage Form : POWDER; INTRAVENOUS
Application Number : 17697
Country : US
Patented : No
Drug : DARZALEX
Dosage Form : INJECTABLE; INJECTION
Application Number : 761036
Country : US
Patented : No
POLYSORBATE 20
Route : AURICULAR (OTIC)
CAS : 9005645
UNII : 7T1F30V5YH
Potency Amount : 0.1
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLYSORBATE 20
Route : IM - SC
CAS : 9005645
UNII : 7T1F30V5YH
Potency Amount : 0.0005
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF